Paper9260591
p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
Günther T and 4 others. J Cancer Res Clin Oncol, 1997. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors. Papers, record 9260591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9260591
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Carcinoma | Major topic |
| Genes, p53 | Major topic |
| Nuclear Proteins | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Adult | |
| Aged | |
| DNA, Neoplasm | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Middle Aged | |
| Mutation | |
| Ploidies | |
| Point Mutation | |
| Polymorphism, Single-Stranded Conformational | |
| Proto-Oncogene Proteins c-mdm2 | |
| Receptors, Estrogen |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8423618 | Prognostic significance of p53 overexpression in node-negative breast carcinoma: preliminary studies support cautious optimism. | J Natl Cancer Inst | 1993 | https://conductscience.org/library/papers/8423618 | PubMed |
| 2 | 1464323 | The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. | EMBO J | 1992 | https://conductscience.org/library/papers/1464323 | PubMed |
| 3 | 1505019 | p53 function and dysfunction. | Cell | 1992 | https://conductscience.org/library/papers/1505019 | PubMed |
| 4 | 2687159 | Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. | Genomics | 1989 | https://conductscience.org/library/papers/2687159 | PubMed |
| 5 | 1984541 | NIH consensus conference. Treatment of early-stage breast cancer. | JAMA | 1991 | https://conductscience.org/library/papers/1984541 | PubMed |
| 6 | 8174045 | Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor. | Cancer | 1994 | https://conductscience.org/library/papers/8174045 | PubMed |
| 7 | 2228312 | Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. | Int J Cancer | 1990 | https://conductscience.org/library/papers/2228312 | PubMed |
| 8 | 1413493 | Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up. | Virchows Arch A Pathol Anat Histopathol | 1992 | https://conductscience.org/library/papers/1413493 | PubMed |
| 9 | 8302577 | DNA synthesis-associated nuclear exclusion of p53 in normal human breast epithelial cells in culture. | Oncogene | 1994 | https://conductscience.org/library/papers/8302577 | PubMed |
| 10 | 8033152 | Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. | Cancer Res | 1994 | https://conductscience.org/library/papers/8033152 | PubMed |
| 11 | 1734086 | Pattern of p53 gene mutations in breast cancers of women of the midwestern United States. | J Natl Cancer Inst | 1992 | https://conductscience.org/library/papers/1734086 | PubMed |
| 12 | 1378473 | An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. | J Immunol Methods | 1992 | https://conductscience.org/library/papers/1378473 | PubMed |
| 13 | 7506924 | Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation. | Br J Cancer | 1994 | https://conductscience.org/library/papers/7506924 | PubMed |
| 14 | 1679056 | Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. | Jpn J Cancer Res | 1991 | https://conductscience.org/library/papers/1679056 | PubMed |
| 15 | 3276632 | P53 expression in breast cancer. | Int J Cancer | 1988 | https://conductscience.org/library/papers/3276632 | PubMed |
| 16 | 7514027 | p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. | Br J Cancer | 1994 | https://conductscience.org/library/papers/7514027 | PubMed |
| 17 | 8252351 | Correlation between p53 mutations and antibody staining in breast carcinoma. | Br J Surg | 1993 | https://conductscience.org/library/papers/8252351 | PubMed |
| 18 | 8287224 | Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives. | Diagn Mol Pathol | 1993 | https://conductscience.org/library/papers/8287224 | PubMed |
| 19 | 1352359 | Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. | J Natl Cancer Inst | 1992 | https://conductscience.org/library/papers/1352359 | PubMed |
| 20 | 1535557 | The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. | Cell | 1992 | https://conductscience.org/library/papers/1535557 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24488925 | The Mdm network and its regulation of p53 activities: a rheostat of cancer risk. | Hum Mutat | 2014 | https://conductscience.org/library/papers/24488925 | PubMed |
| 16154258 | Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis. | Cancer Lett | 2006 | https://conductscience.org/library/papers/16154258 | PubMed |
| 15856018 | Oxidized guanine lesions and hOgg1 activity in lung cancer. | Oncogene | 2005 | https://conductscience.org/library/papers/15856018 | PubMed |
| 15064746 | Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint. | Oncogene | 2004 | https://conductscience.org/library/papers/15064746 | PubMed |
| 11250701 | Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer. | Breast Cancer Res | 2000 | https://conductscience.org/library/papers/11250701 | PubMed |
| 10189892 | Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol. | Jpn J Cancer Res | 1999 | https://conductscience.org/library/papers/10189892 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| MDM2 | 4193 | PubTator's text mining | https://conductscience.org/library/genes/4193 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9260591
GET https://conductscience.org/api/papers/v1/9260591/references?page=2